Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Neurodevelopmental Outcome
100%
Prednisolone
100%
Methylprednisolone
100%
Extremely Preterm Infants
100%
Corticosteroids
80%
Gestational Age
60%
Cumulative Dose
60%
Neonatal Intensive Care Unit
40%
Corrected Age
40%
Bayley Scales of Infant Development
40%
Third Edition
40%
Neurodevelopment
20%
Neuroprotection
20%
Clinical Conditions
20%
Low Birth Weight
20%
Erythropoietin
20%
Treatment Duration
20%
Demographic Characteristics
20%
Clinical Characteristics
20%
Replication Study
20%
Randomized Clinical Trial
20%
Potential Confounders
20%
Motor Domain
20%
Limited Information
20%
Bronchopulmonary Dysplasia
20%
Practice Variability
20%
Exposed Infants
20%
Intensive Care Unit Stay
20%
Language Domain
20%
Nursing and Health Professions
Dexamethasone
100%
Methylprednisolone
100%
Prednisolone
100%
Corticosteroid
44%
Gestational Age
33%
Neonatal Intensive Care Unit
22%
Bayley Scales of Infant Development
22%
Treatment Duration
11%
Cohort Analysis
11%
Lung Dysplasia
11%
Low Birth Weight
11%
Erythropoietin
11%
Neuroprotection
11%
Data Processing
11%
Clinical Trial
11%
Medicine and Dentistry
Dexamethasone
100%
Methylprednisolone
100%
Prednisolone
100%
Corticosteroid
44%
Gestational Age
33%
Neonatal Intensive Care Unit
22%
Bayley Scales of Infant Development
22%
Cohort Analysis
11%
Neuroprotection
11%
Low Birth Weight
11%
Lung Dysplasia
11%
Treatment Duration
11%
Erythropoietin
11%
Randomized Clinical Trials
11%
Pharmacology, Toxicology and Pharmaceutical Science
Dexamethasone
100%
Methylprednisolone
100%
Prednisolone
100%
Corticosteroid
44%
Cohort Study
11%
Neuroprotection
11%
Randomized Clinical Trial
11%
Lung Dysplasia
11%
Low Birth Weight
11%
Erythropoietin
11%
Neuroscience
Dexamethasone
100%
Methylprednisolone
100%
Prednisolone
100%
Corticosteroid
44%
Neuroprotection
11%
Erythropoietin
11%
Dysplasia
11%